Related Experiment Video
Updated: Aug 8, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope
D López1, Y Samino, U H Koszinowski
1Centro Nacional de Biología Fundamental, Instituto de Salud Carlos III, Madrid, Spain.
Insights
Viral antigens expressed together can compete for presentation by MHC class I molecules. This competition can impair T-cell recognition, impacting vaccine development and immunodominance understanding.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Cytotoxic T Lymphocytes (CTLs) recognize viral peptides presented by MHC class I molecules.
- Understanding antigen competition is crucial for vaccine design and immune response modulation.
Purpose of the Study:
- To investigate whether co-expressed viral antigens compete for presentation by MHC class I molecules.
- To determine the impact of this competition on CTL recognition.
Main Methods:
- Coexpression of HIV-1 envelope (ENV) and CMV pp89 phosphoprotein epitopes restricted by MHC L(d).
- Assessment of CTL recognition of CMV pp89 epitope in the presence of HIV ENV.
- Analysis of naturally processed peptide-MHC class I complex formation.
Main Results:
- HIV ENV strain IIIB, but not MN, impaired CTL recognition of the CMV pp89 epitope.
- Inhibition was inversely related to the amount of processed CMV peptide.
- Competition reduced the yield of naturally processed CMV peptide bound to MHC class I.
Conclusions:
- Viral antigens can interfere with each other's presentation by MHC class I molecules.
- Competition occurs during MHC-peptide complex assembly or stabilization.
- Antigen competition has implications for vaccine strategies and immunodominance.
Abstract:
CTL recognize peptides that derive from viral protein Ags by proteolytic processing and are presented by MHC class I molecules. In this study we tested whether coexpression of viral Ags in the same cell leads to competition between them. To this end, two L(d)-restricted epitopes derived from HIV-1 envelope gp160 (ENV) and from CMV pp89 phosphoprotein were coexpressed. HIV ENV strain IIIB, but not MN variant, impaired recognition by specific CTL of CMV pp89 epitope 9pp89. Susceptibility to inhibition after ENV coexpression was inversely related to the amount of antigenic 9pp89 peptide processed from different antigenic constructs. In line with it, competition decreased the yield of naturally processed antigenic 9pp89 peptide bound to MHC class I molecules in coinfected cells. Also, point mutants of the presenting MHC class I molecule differed in their competition pattern. Collectively, the data imply that competition operates at the step of MHC-peptide complex assembly or stabilization. We conclude that, although not the rule, in certain combinations there is interference between different Ags expressed in the same cell and presented by the same MHC class I allele. These studies have implications for vaccine development and for understanding immunodominance.
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

